O

Otonomy Inc
F:7OT

Watchlist Manager
Otonomy Inc
F:7OT
Watchlist
Price: 0.0626 EUR 0.64% Market Closed
Market Cap: 11.4m EUR

Relative Value

7OT price has not been updated for more than 3 weeks. This may indicate that the stock has been delisted.
7OT doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of 7OT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

7OT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.7
Forward
94.3
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.3
Industry
21.6
Forward
-0.3
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.3
Industry
16.9
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.3
Industry
22.9
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.6
Industry
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3
Forward
-190.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.5
Industry
13.4
vs History
vs Industry
Median 3Y
0.5
Median 5Y
0.5
Industry
16.7
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.6
Industry
16.1
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.6
Industry
18.9
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
2

Multiples Across Competitors

7OT Competitors Multiples
Otonomy Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Otonomy Inc
F:7OT
11.4m EUR 0 -0.3 0.5 0.5
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
275.3B CHF 4.5 29.2 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
217.5B GBP 5 31 108.3 158.5
CH
Novartis AG
SIX:NOVN
219.7B CHF 4.9 19 12 15.5
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/S Multiple
Revenue Growth P/S to Growth
US
O
Otonomy Inc
F:7OT
Average P/S: 71.9
Not Available
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
16.4
26%
0.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
9%
64.3
US
Johnson & Johnson
NYSE:JNJ
5.7
6%
1
CH
Roche Holding AG
SIX:ROG
4.5
3%
1.5
UK
AstraZeneca PLC
LSE:AZN
5
8%
0.6
CH
Novartis AG
SIX:NOVN
4.9
5%
1
US
Merck & Co Inc
NYSE:MRK
4.3
4%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
5.1
5%
1
IE
E
Endo International PLC
LSE:0Y5F
92.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
2.3
-2%
N/A
P/E Multiple
Earnings Growth PEG
US
O
Otonomy Inc
F:7OT
Average P/E: 24.8
Negative Multiple: -0.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.2
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
O
Otonomy Inc
F:7OT
Average EV/EBITDA: 400
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
O
Otonomy Inc
F:7OT
Average EV/EBIT: 1 712.4
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5